17.5 C
London
Sunday, September 14, 2025
HomeNewsPfizer's Vaccine Protects Less Than Moderna's Because They Wanted To Minimize Side...

Pfizer’s Vaccine Protects Less Than Moderna’s Because They Wanted To Minimize Side Effects

Date:

Related stories

Ecommpay achieves double shortlisting at the UK eCommerce Awards

Ecommpay, the inclusive global payments platform, has secured two...

Singapore’s Carro Accelerates Global Expansion with Australia Entry and Stock Market Plans

A disruptive growth strategy, including aggressive acquisitions and takeovers,...

How to Win QLD Workers Compensation Benefits

In Queensland, securing workers' compensation benefits after a workplace injury...

Tipple secures €4M seed funding to reshape the $1.6 trillion global alcohol industry

Tipple, a Dublin-based startup founded by gin distiller turned...

Pfizer’s vaccine contains 70 micrograms less of the active ingredient than Moderna’s. The intention of the pharmaceutical company, as explained by the scientific director of the company, was to reduce the side effects of the injection. “We used the lowest dose level that recorded an immune response in older adults superior to the immune response we saw after natural infection,” said Philip Dormitzer, principal scientist at Pfizer.

However, several studies show that Moderna’s vaccine elicits a stronger and longer-lasting immune response than its counterpart. Some scientists blame this reaction on Moderna’s messenger RNA dose is more than triple that of Pfizer, 100 micrograms and 30 micrograms , respectively.

Pfizer faces criticism from experts and global policymakers
It should be noted that the company is in the midst of a war with various world legislators and experts. Pfizer faces strong criticism and the accusation of pressuring the US government to launch a third dose of its vaccine , when the debate on whether a third booster is necessary is still open.

In this sense, the chief scientist of the World Health Organization, whose job it is to ensure that developing countries are immunized, has assured that the existing data “does not indicate that reinforcements are needed . “

Despite this, Dormitzer defended his pharmacist in an interview with the Financial Times . “The decision to implement the solutions was for the policy makers, not for Pfizer,” he said.

Sam Allcock
Sam Allcockhttps://prfire.co.uk
Sam Allcock is the founder of PR Fire. He helps small to medium-sized businesses land coverage in publications like BuzzFeed, Metro, The Huffington Post, and The Telegraph through smart press release distribution. Contact: Sam@prfire.com

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories

LEAVE A REPLY

Please enter your comment!
Please enter your name here